Wild-type and splice-variant secretin receptors in lung cancer: overexpression in carcinoid tumors and peritumoral lung tissue.

Wild-type and splice-variant secretin receptors in lung cancer: overexpression in carcinoid tumors and peritumoral lung tissue. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Wild-type and splice-variant secretin receptors in lung cancer: overexpression in carcinoid tumors and peritumoral lung tissue. Abstract Text:

Meike U ,Gregory M Hayes,Patricia E Carrigan,Ruth Rehmann,Laurence J Miller,Jean C Reubi,

Gastrointestinal peptide hormone receptors, like somatostatin receptors, are often overexpressed in human cancer, allowing receptor-targeted tumor imaging and therapy. A novel candidate for these applications is the secretin receptor recently identified in pancreatic and cholangiocellular carcinomas. In the present study, secretin receptors were assessed in a non-gastrointestinal tissue, the human lung. Non-small-cell lung cancers (n=26), small-cell lung cancers (n=10), bronchopulmonary carcinoid tumors (n=29), and non-neoplastic lung (n=46) were investigated for secretin receptor protein expression with in vitro receptor autoradiography, using (125)I-[Tyr(10)] rat secretin and for secretin receptor transcripts with RT-PCR. Secretin receptor protein expression was found in 62% of bronchopulmonary carcinoids in moderate to high density, in 12% of non-small cell lung cancers in low density, but not in small cell lung cancers. In tumors found to be secretin receptor positive by autoradiography, RT-PCR revealed transcripts for the wild-type secretin receptor and for novel secretin receptor splice variants. In the non-neoplastic lung, secretin receptor protein expression was observed in low density along the alveolar septa in direct tumor vicinity in cases of acute inflammation, but not in histologically normal lung. In the autoradiographically positive peritumoral lung, RT-PCR showed transcripts for the wild-type secretin receptor and for a secretin receptor spliceoform different from those occurring in lung and gut tumors. In conclusion, secretin receptors are new markers for bronchopulmonary carcinoid tumors, and represent the molecular basis for an in vivo targeting of carcinoid tumors for diagnosis and therapy. Furthermore, secretin receptors may play a role in peritumoral lung pathophysiology. Secretin receptor mis-splicing specifically occurs in tumor and non-tumor lung pathology.Modern Pathology (2008) 21, 387-395; doi:10.1038/modpathol.3801005; published online 25 January 2008.

Wild-type and splice-variant secretin receptors in lung cancer: overexpression in carcinoid tumors and peritumoral lung tissue. Publishing Authors By Initials

MU ,GM Hayes,PE Carrigan,R Rehmann,LJ Miller,JC Reubi,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Wild-type and splice-variant secretin receptors in lung cancer: overexpression in carcinoid tumors and peritumoral lung tissue. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Modern pathology : an official journal of the Unit

VOLUME: 21

Page Numbers: 387-95

Journal Abbreviation: Mod. Pathol.

ISSN: 0893-3952

DAY: 25

MONTH: 01

YEAR: 2008

Wild-type and splice-variant secretin receptors in lung cancer: overexpression in carcinoid tumors and peritumoral lung tissue. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8806605

Wild-type and splice-variant secretin receptors in lung cancer: overexpression in carcinoid tumors and peritumoral lung tissue. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Wild-type and splice-variant secretin receptors in lung cancer: overexpression in carcinoid tumors and peritumoral lung tissue. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Wild-type and splice-variant secretin receptors in lung cancer: overexpression in carcinoid tumors and peritumoral lung tissue.

AFFILIATION: 1Division of Cell Biology and Experimental Cancer Research, Institute of Pathology of the University of Bern, Bern, Switzerland.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Mod Pathol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Wild-type and splice-variant secretin receptors in lung cancer: overexpression in carcinoid tumors and peritumoral lung tissue Related Publications

• Blood pressure, circulating renin and the body sodium/volume state in patients with mild renal failure.
• CRF receptors in the rodent and human cardiovascular systems: species differences.
• GPR87 is an overexpressed G-protein coupled receptor in squamous cell carcinoma of the lung.
• Haemodynamic and blood volume studies in long-term haemodialysis patients, and in patients with successfully transplanted kidneys.
• Not Available
• Overexpression of gastrin-releasing peptide receptors in tumor-associated blood vessels of human ovarian neoplasms.
• Peptide receptor expression in GEP-NET.
• Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors.
• Secretin receptors in the human liver: expression in biliary tract and cholangiocarcinoma, but not in hepatocytes or hepatocellular carcinoma.
• The effect of cochlear nerve lesion on the release of glutamate, aspartate, and GABA from cat cochlear nucleus, in vitro.
• Wild-type and splice-variant secretin receptors in lung cancer: overexpression in carcinoid tumors and peritumoral lung tissue.
• [ALDOMET IN THE AMBULATORY TREATMENT OF HYPERTENSION. PERSONAL EXPERIENCES AND STUDIES ON RENAL HEMODYNAMICS.]
• [Are the so-called cerebroactive drugs really useful?]
• [Conservative therapy of chronic renal failure]
• [Exchangeable sodium, fluid space and hypertonia in chronic uremia]
• [Hemodynamic properties of two new phthalazine derivatives.]
• [Immunosuppression]
• [Importance of Kaplan's hypertension testing the etiologic diagnosis of hypertension]
• [Kidney function and antibiotic dosage]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Practical recommendations for antihypertensive therapy (author's transl)]
• [The behavior of renal hemodynamics in hydroxydione anesthesia.]
• [The classification of glomerulonephritis (author's transl)]
• [The present status of treatment of chronic renal insufficiency.]
• [Therapeutic tests and "ex juvantibus" diagnosis (author's transl)]
• [Treatment of circulatory collapse and shock.]
• [What the general practitioner should know about electrolytes.]